A Bipartisan Approach on Drug Prices Is Emerging
- Lawmakers looking at drug-industry tactics to keep costs high
- Sen. Paul says he sees possibility of a ‘bipartisan agreement’
This article is for subscribers only.
Congress has found little to agree on when it comes to health care, but lawmakers from both parties appear to be warming up to ideas for reining in drug prices.
While soaring prescription costs have drawn fire from across the political spectrum, action has been scant. There are signs however that a consensus is forming on Capitol Hill on how to curtail tactics that shield blockbuster medicines from competition.